Nanoparticles for mucosal vaccine delivery

Department of Pharmacy

Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

Standard

Nanoparticles for mucosal vaccine delivery. / Thakur, Aneesh; Foged, Camilla.

Nanoengineered Biomaterials for Advanced Drug Delivery. Woodhead Publishing, 2020. p. 603-646.

Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

Harvard

Thakur, A & Foged, C 2020, Nanoparticles for mucosal vaccine delivery. in Nanoengineered Biomaterials for Advanced Drug Delivery. Woodhead Publishing, pp. 603-646. https://doi.org/10.1016/B978-0-08-102985-5.00025-5

APA

Thakur, A., & Foged, C. (2020). Nanoparticles for mucosal vaccine delivery. In Nanoengineered Biomaterials for Advanced Drug Delivery (pp. 603-646). Woodhead Publishing. https://doi.org/10.1016/B978-0-08-102985-5.00025-5

Vancouver

Thakur A, Foged C. Nanoparticles for mucosal vaccine delivery. In Nanoengineered Biomaterials for Advanced Drug Delivery. Woodhead Publishing. 2020. p. 603-646 https://doi.org/10.1016/B978-0-08-102985-5.00025-5

Author

Thakur, Aneesh ; Foged, Camilla. / Nanoparticles for mucosal vaccine delivery. Nanoengineered Biomaterials for Advanced Drug Delivery. Woodhead Publishing, 2020. pp. 603-646

Bibtex

@inbook{efd536934be844f8ad4e51d7b0648506,

title = "Nanoparticles for mucosal vaccine delivery",

abstract = "Mucosal surfaces represent important routes of entry into the human body for the majority of pathogens, and they constitute unique sites for targeted vaccine delivery. Nanoparticle-based drug delivery systems are emerging technologies for delivering and improving the efficacy of mucosal vaccines. Recent studies have provided new insights into formulation and delivery aspects of importance for the design of safe and efficacious mucosal subunit vaccines based on nanoparticles. These include novel nanomaterials, their physicochemical properties and formulation approaches, nanoparticle interaction with immune cells in the mucosa, and mucosal immunization and delivery strategies. Here, we present recent progress in the application of nanoparticle-based approaches for mucosal vaccine delivery and discuss future research challenges and opportunities in the field.",

keywords = "Adjuvants, Drug delivery, Mucosal immunization, Nanoparticles, Vaccines",

author = "Aneesh Thakur and Camilla Foged",

year = "2020",

doi = "10.1016/B978-0-08-102985-5.00025-5",

language = "English",

pages = "603--646",

booktitle = "Nanoengineered Biomaterials for Advanced Drug Delivery",

publisher = "Woodhead Publishing",

}

RIS

TY - CHAP

T1 - Nanoparticles for mucosal vaccine delivery

AU - Thakur, Aneesh

AU - Foged, Camilla

PY - 2020

Y1 - 2020

N2 - Mucosal surfaces represent important routes of entry into the human body for the majority of pathogens, and they constitute unique sites for targeted vaccine delivery. Nanoparticle-based drug delivery systems are emerging technologies for delivering and improving the efficacy of mucosal vaccines. Recent studies have provided new insights into formulation and delivery aspects of importance for the design of safe and efficacious mucosal subunit vaccines based on nanoparticles. These include novel nanomaterials, their physicochemical properties and formulation approaches, nanoparticle interaction with immune cells in the mucosa, and mucosal immunization and delivery strategies. Here, we present recent progress in the application of nanoparticle-based approaches for mucosal vaccine delivery and discuss future research challenges and opportunities in the field.

AB - Mucosal surfaces represent important routes of entry into the human body for the majority of pathogens, and they constitute unique sites for targeted vaccine delivery. Nanoparticle-based drug delivery systems are emerging technologies for delivering and improving the efficacy of mucosal vaccines. Recent studies have provided new insights into formulation and delivery aspects of importance for the design of safe and efficacious mucosal subunit vaccines based on nanoparticles. These include novel nanomaterials, their physicochemical properties and formulation approaches, nanoparticle interaction with immune cells in the mucosa, and mucosal immunization and delivery strategies. Here, we present recent progress in the application of nanoparticle-based approaches for mucosal vaccine delivery and discuss future research challenges and opportunities in the field.

KW - Adjuvants

KW - Drug delivery

KW - Mucosal immunization

KW - Nanoparticles

KW - Vaccines

U2 - 10.1016/B978-0-08-102985-5.00025-5

DO - 10.1016/B978-0-08-102985-5.00025-5

M3 - Book chapter

AN - SCOPUS:85096934998

SP - 603

EP - 646

BT - Nanoengineered Biomaterials for Advanced Drug Delivery

PB - Woodhead Publishing

ER -

ID: 299271932